There is a great deal of debate about health care. It seems no two studies agree. One task force suggests a set of criteria and the next the opposite. To make matters worse, recommended changes that go against the accepted norm for patients are often opposed.
One thing is clear; unnecessary, duplicative and ineffective health care all contribute to spending and hence the premiums we pay.
Healthcare consumers spend $25 billion each year on low-value health procedures that aren’t always necessary, according to the Task Force on Low-Value Care, a multi-stakeholder group established by VBID Health.
The five most commonly overused low-value medical procedures, according to the task force, are: 1) diagnostic imaging and testing for low-risk patients before they undergo low-risk surgery; 2) vitamin D screening; 3) screening of men 75 and older for prostate-specific antigen; 4) imaging for acute lower-back pain the first six weeks after symptoms appeared without clinical warning signs; and 5) using expensive brand-name drugs when generics with the same active ingredients are available.
Each of these five procedures have “broad scientific consensus against their use,” according to the task force.